HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of primary biliary cirrhosis after liver transplantation.

Abstract
Three patients who had undergone orthrotopic liver transplantation for primary biliary cirrhosis and were being maintained on immunosuppressive therapy were investigated 31/2 to 41/2 years later because of the redevelopment of pruritus and mild jaundice. In one patient pigmentation was again evident, and all three had a rise in the titer of serum mitochondrial antibody after an initial fall. Liver histology showed features of primary biliary cirrhosis with non-suppurative destructive cholangitis, lymphoid aggregates, and increased deposition of copper-binding protein in the absence of cholestasis. None of these features was found in patients who had received grafts for other conditions and had lived for comparable periods, nor were they found in patients who had had rejection with bile-duct abnormalities. The overall findings indicate a recurrence of primary biliary cirrhosis in the donor organ.
AuthorsJ Neuberger, B Portmann, B R Macdougall, R Y Calne, R Williams
JournalThe New England journal of medicine (N Engl J Med) Vol. 306 Issue 1 Pg. 1-4 (Jan 07 1982) ISSN: 0028-4793 [Print] United States
PMID7031471 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • Immunosuppressive Agents
Topics
  • Adult
  • Antigen-Antibody Complex (analysis)
  • Autoantibodies (analysis)
  • Female
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Liver (pathology)
  • Liver Cirrhosis, Biliary (immunology, pathology, surgery)
  • Liver Transplantation
  • Male
  • Middle Aged
  • Mitochondria, Liver (immunology)
  • Recurrence
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: